Popular diabetes drugs may impact colonoscopy prep quality

NCT ID NCT07127354

Recruiting now Knowledge-focused Sponsor: The Cleveland Clinic Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at how GLP-1 and GIP agonists (medications used for diabetes and weight loss) affect bowel preparation quality in adults scheduled for a colonoscopy. Researchers want to see if these drugs increase the chance of poor bowel prep, and whether pausing the medication for one dose improves outcomes. About 132 participants will be randomly assigned to either hold or continue their medication before the procedure.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BOWEL PREPARATION FOR COLONOSCOPY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BOWEL PREPARATION FOR COLONOSCOPY GLP-1

Contacts and locations

Show contact details

Locations

Cleveland Clinic
RECRUITING

Cleveland, Florida, 44195, United States
Cleveland Clinic
RECRUITING

Cleveland, Florida, 44195, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact
Cleveland Clinic Weston
RECRUITING

Weston, Florida, 33331, United States

Contact Email: •••••@•••••

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact

More trials for these conditions

Other studies related to the condition(s) this trial covers.